Arca Biopharma, Inc. News - ABIO

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Arca Biopharma, Inc. ABIO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 6.24 0.00 0.00 0.00 6.24 06:59:52
more quote information »

Recent News

Date Time Source Heading
5/20/201916:29EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/20/201916:06EDGARCurrent Report Filing (8-k)
5/17/201913:12EDGARConfidential Treatment Order (ct Order)
5/13/201909:00GLOBEARCA biopharma Announces Submission of Patent Application to..
5/09/201916:47EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/09/201916:22EDGARCurrent Report Filing (8-k)
5/08/201916:50EDGARCurrent Report Filing (8-k)
5/08/201916:30GLOBEARCA Biopharma Announces First Quarter 2019 Financial..
5/08/201916:18EDGARQuarterly Report (10-q)
5/01/201908:30GLOBEGENETIC-AF Phase 2B Trial Results Published in the Journal..
4/23/201908:30GLOBEARCA biopharma Announces Steering Committee of Leading..
4/22/201916:06EDGARCurrent Report Filing (8-k)
4/05/201916:18EDGARCurrent Report Filing (8-k)
4/03/201916:09EDGARCurrent Report Filing (8-k)
3/20/201916:08EDGARCurrent Report Filing (8-k)
3/18/201908:30GLOBEIdentification of Phosphodiesterease 3A Polymorphism With..
3/11/201917:13EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/11/201917:05EDGARCurrent Report Filing (8-k)
3/06/201908:00GLOBEDose Response of Beta-Blockers in Adrenergic Receptor..
2/27/201916:34EDGARCurrent Report Filing (8-k)
2/27/201916:15GLOBEARCA biopharma Announces Fiscal Year 2018 Financial Results..
2/27/201916:05EDGARAnnual Report (10-k)
2/20/201907:47EDGARCurrent Report Filing (8-k)
2/20/201907:30GLOBEARCA Biopharma Announces FDA Agreement for a Single Phase 3..
2/12/201913:53EDGARStatement of Ownership (sc 13g)
2/12/201909:06EDGARAmended Statement of Ownership (sc 13g/a)
1/25/201916:48EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/16/201908:30GLOBEZosano Appoints Linda Grais M.D., J.D. to Board of Directors
12/20/201816:32EDGARCurrent Report Filing (8-k)
12/20/201816:01GLOBEARCA biopharma Updates Special Protocol Assessment Request..
11/14/201817:02EDGARCurrent Report Filing (8-k)
11/14/201816:58EDGARQuarterly Report (10-q)
11/12/201808:30GLOBEGENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation..
11/05/201808:30GLOBEARCA Biopharma announces phase 2B GENETIC-AF atrial..
10/18/201816:17EDGARCurrent Report Filing (8-k)
10/09/201816:19EDGARCurrent Report Filing (8-k)
9/20/201816:09EDGARProxy Statement (definitive) (def 14a)
9/18/201816:12EDGARCurrent Report Filing (8-k)
9/18/201808:30GLOBEARCA biopharma Submits Special Protocol Assessment Request..
9/10/201817:19EDGARProxy Statement - Notice of Shareholders Meeting..
8/09/201816:39EDGARCurrent Report Filing (8-k)
8/09/201816:32EDGARQuarterly Report (10-q)
8/09/201816:15GLOBEARCA biopharma Announces Second Quarter 2018 Financial..
7/31/201816:19EDGARCurrent Report Filing (8-k)
7/31/201808:30GLOBEARCA Biopharma Announces Positive Outcome of End-of-Phase 2..
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.